Athena Global Technologies Completes Healthcare Unit Acquisition and Divestment in Corporate Restructuring

2 min read     Updated on 01 Apr 2026, 07:08 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Athena Global Technologies Limited completed a corporate restructuring on March 31, 2026, involving the acquisition of 100% equity in MedleyMed Healthcare Solutions Private Limited for Rs. 10,000 and the divestment of Medley Medical Solutions Private Limited for Rs. 1.25 crores. Both related party transactions were conducted at arm's length to consolidate the group's healthcare and trading operations under one entity.

powered bylight_fuzz_icon
36553085

*this image is generated using AI for illustrative purposes only.

Athena Global Technologies Limited has announced the completion of a strategic corporate restructuring involving the acquisition and divestment of healthcare subsidiaries. The board of directors approved these transactions during their meeting held on March 31, 2026, aimed at consolidating the group's healthcare and trading operations.

Acquisition Details

The company has acquired 100% equity shareholding of MedleyMed Healthcare Solutions Private Limited, converting it into a wholly owned subsidiary. The acquisition represents a strategic move to strengthen the company's position in healthcare logistics and pharmaceutical trading operations.

Parameter: Details
Target Company: MedleyMed Healthcare Solutions Private Limited
CIN: U24239TG2019PTC136763
Acquisition Cost: Rs. 10,000
Equity Stake: 100%
Transaction Type: Cash consideration
Completion Date: March 31, 2026

MedleyMed Healthcare Solutions, incorporated on November 14, 2019, specializes in healthcare logistics and pharmaceutical trading operations. The company operates as a small-scale unit and has shown varying financial performance over recent years.

Financial Performance of Acquired Entity

The target company's turnover history demonstrates significant fluctuations in business performance:

Financial Year: Turnover (Lakhs)
FY-2025: 44.18
FY-2024: 299.75
FY-2023: 299.95

Divestment Transaction

Simultaneously, Athena Global Technologies has divested its stake in Medley Medical Solutions Private Limited as part of the restructuring exercise. This divestment complements the acquisition strategy by streamlining the group's healthcare operations.

Parameter: Details
Divested Company: Medley Medical Solutions Private Limited
CIN: U93000TG2016PTC111660
Sale Consideration: Rs. 1,25,33,689
Buyer: MedleyMed Healthcare Solutions Private Limited
Expected Completion: March 31, 2026

Financial Impact and Contribution

The divested entity's contribution to the consolidated financials as of September 30, 2025, was relatively modest:

  • Income Contribution: 0.17% of total consolidation income (0.94 lakhs)
  • Net Worth Contribution: 0.39% of total consolidation net worth (55.95 lakhs)

Regulatory Compliance and Structure

Both transactions qualify as related party transactions conducted at arm's length basis. The acquisition requires no specific government approvals beyond standard compliance under the Companies Act, 2013 and SEBI regulations. The restructuring aims to consolidate group healthcare and trading businesses under one entity for improved operational efficiency.

The board meeting commenced at 6:30 PM and concluded at 7:15 PM on March 31, 2026, with all necessary approvals obtained for both transactions. These strategic moves reflect the company's commitment to optimizing its healthcare business portfolio through focused consolidation.

Historical Stock Returns for Athena Global Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-1.21%-0.72%-15.44%-31.97%-26.95%+77.46%

How will Athena Global Technologies address the significant revenue decline in MedleyMed Healthcare Solutions from Rs. 299.75 lakhs in FY-2024 to Rs. 44.18 lakhs in FY-2025?

What synergies does Athena expect to achieve by consolidating its healthcare operations, and what is the projected timeline for operational integration?

Will this restructuring lead to further acquisitions in the healthcare logistics sector or expansion into new pharmaceutical trading markets?

Athena Global Technologies
View Company Insights
View All News
like16
dislike

Athena Global Technologies Submits EGM Voting Results to BSE

2 min read     Updated on 27 Mar 2026, 12:58 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Athena Global Technologies Limited has successfully submitted the voting results and scrutinizer report for its March 25, 2026 Extra-Ordinary General Meeting to BSE. All three resolutions were passed unanimously, including warrant issuance to promoters, reappointment of Chairman & Managing Director M. Satyendra, and approval for material related party transactions with Medley Medical Solutions Private Limited.

powered bylight_fuzz_icon
35549494

*this image is generated using AI for illustrative purposes only.

Athena Global Technologies Limited has submitted the voting results and scrutinizer report for its Extra-Ordinary General Meeting held on March 25, 2026, to the BSE under Regulation 44 of SEBI (LODR) Regulations 2015. The company successfully conducted the EGM through Video Conferencing and Other Audio Visual Means, with all three resolutions passed by requisite majority.

EGM Overview and Participation

The EGM was conducted on March 25, 2026, at 12:00 Noon through VC/OAVM, chaired by M Satyendra, Chairman & Managing Director. The meeting addressed three key business items including warrant issuance, director reappointment, and material related party transactions.

Parameter Details
Total Shareholders (Record Date) 8,150
Shareholders Attended via VC 59
E-Voting Period March 22-24, 2026
Meeting Duration 12:00 Noon to 12:27 Noon IST

Voting Results Summary

All three resolutions were passed with 100% votes in favor, demonstrating strong shareholder support. The voting process was conducted through remote e-voting and insta-poll mechanisms, supervised by scrutinizer Jineshwar Kumar Sankhala from P.S. Rao & Associates.

Resolution 1: Warrant Issuance (Special Resolution)

Issuance of up to 7,00,000 warrants convertible into equity shares to promoter on preferential basis received unanimous approval.

Category Shares Held Votes Polled Votes in Favor % in Favor
Promoter Group 9,281,938 9,281,938 9,281,938 100.00%
Public Non-Institutions 5,429,650 1,012,807 1,012,807 100.00%
Total 14,711,588 10,294,745 10,294,745 100.00%

Resolution 2: Director Reappointment (Special Resolution)

Re-appointment of M. Satyendra as Chairman & Managing Director was approved with total votes of 3,304,133.

Category Votes Polled Votes in Favor % Polling
Promoter Group 2,291,326 2,291,326 24.69%
Public Non-Institutions 1,012,807 1,012,807 18.65%
Total 3,304,133 3,304,133 22.46%

Resolution 3: Related Party Transactions (Ordinary Resolution)

Approval for material related party transactions with Medley Medical Solutions Private Limited received the same voting pattern as Resolution 1.

Scrutinizer Report and Compliance

Jineshwar Kumar Sankhala, Practicing Company Secretary from P.S. Rao & Associates, served as the appointed scrutinizer. The report confirmed that all resolutions were passed by requisite majority with 71 members voting in favor across all three resolutions and zero votes against any resolution.

The company utilized Central Depository Services (India) Limited (CDSL) for the electronic voting facility, ensuring compliance with MCA circulars and SEBI Listing Regulations. The cut-off date for determining eligible shareholders was March 18, 2026.

Regulatory Submission

Company Secretary Gayathri Prithviraj submitted the comprehensive voting results and scrutinizer report to BSE on March 26, 2026, fulfilling regulatory obligations under Section 108 of the Companies Act, 2013 and Regulation 44(3) of SEBI (LODR) Regulations 2015. The detailed results are also available on the company's website at www.athenagt.com .

Historical Stock Returns for Athena Global Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-1.21%-0.72%-15.44%-31.97%-26.95%+77.46%

How will the issuance of 7,00,000 warrants to promoters impact the company's ownership structure and dilution for existing shareholders?

What specific business expansion or strategic initiatives is Athena Global Technologies planning to fund with the capital raised from warrant conversion?

What is the nature and financial scope of the material related party transactions approved with Medley Medical Solutions Private Limited?

Athena Global Technologies
View Company Insights
View All News
like18
dislike

More News on Athena Global Technologies

1 Year Returns:-26.95%